Medroxyprogesterone vs Sildenafil Citrate: side-by-side comparison
Medroxyprogesterone (Progestin) and Sildenafil Citrate (PDE5 inhibitor) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Medroxyprogesterone | Sildenafil Citrate |
|---|---|---|
| Therapeutic class | Progestin | PDE5 inhibitor |
| CAS | 520-85-4 | 171599-83-0 |
| ATC | G03DA02 | G04BE03 |
| Molecular weight | 344.49 g/mol | 666.7 g/mol |
| Brands with this active ingredient | 1 | 10 |
What they share
Medroxyprogesterone and Sildenafil Citrate share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Medroxyprogesterone acts by a different mechanism than Sildenafil Citrate, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Medroxyprogesterone: La médroxyprogestérone se lie aux récepteurs de la progestérone et exerce de puissants effets progestatifs : épaississement de la glaire cervicale, inhibition de l'ovulation, amincissement de l'endomètre et réduction des… Sildenafil Citrate: Le citrate de sildénafil inhibe sélectivement la phosphodiestérase de type 5 (PDE5), l'enzyme qui dégrade le guanosine monophosphate cyclique dans le corps caverneux.
Indications compared
Medroxyprogesterone: La médroxyprogestérone est autorisée dans l'aménorrhée, les saignements utérins anormaux d'origine hormonale, la prévention de l'hyperplasie endométriale chez la femme ménopausée recevant un estrogène, et la prévention d… Sildenafil Citrate: Le citrate de sildénafil est autorisé chez l'homme adulte dans le traitement de la dysfonction érectile.
Safety profile
Medroxyprogesterone: Les effets indésirables fréquents de la forme orale comprennent saignements irréguliers, tension mammaire, variations de l'humeur, rétention hydrique et prise de poids. Sildenafil Citrate: Les effets indésirables fréquents rapportés dans les essais cliniques comprennent céphalées, bouffées vasomotrices du visage, congestion nasale, dyspepsie et troubles visuels transitoires.
Questions fréquentes
Is Medroxyprogesterone better than Sildenafil Citrate? ▾
Medroxyprogesterone and Sildenafil Citrate are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Medroxyprogesterone and Sildenafil Citrate be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Medroxyprogesterone
Products with Sildenafil Citrate
Les informations publiées sur ce site sont fournies à titre documentaire et pédagogique. Elles ne remplacent pas l'avis d'un professionnel de santé qualifié.